137 related articles for article (PubMed ID: 8090580)
1. Expression of placental proteins in complete and partial hydatidiform moles.
Cheah PL; Looi LM
Pathology; 1994 Apr; 26(2):115-8. PubMed ID: 8090580
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemistry of molar and non-molar placentas with special reference to their differential diagnosis.
Fukunaga M; Miyazawa Y; Sugishita M; Ushigome S
Acta Pathol Jpn; 1993 Nov; 43(11):683-9. PubMed ID: 7508673
[TBL] [Abstract][Full Text] [Related]
3. [Trophoblastic disease. I. Use of immunohistochemistry in the diagnosis of complete hydatidiform moles].
Danihel L; Porubský J; Zaviacic T; Vojtassák J; Breitenecker G
Cesk Patol; 1994 Aug; 30(3):76-9. PubMed ID: 7923420
[TBL] [Abstract][Full Text] [Related]
4. Immunocytochemical localization of chorionic gonadotropin, placental lactogen, and placental alkaline phosphatase in the diagnosis of complete and partial hydatidiform moles.
Brescia RJ; Kurman RJ; Main CS; Surti U; Szulman AE
Int J Gynecol Pathol; 1987; 6(3):213-29. PubMed ID: 3429106
[TBL] [Abstract][Full Text] [Related]
5. [Trophoblastic disease. II. Immunohistochemical and cytogenetic parameters of partial hydatidiform moles].
Danihel L; Porubský J; Vojtassák J; Breitenecker G
Cesk Patol; 1994 Aug; 30(3):80-4. PubMed ID: 7923421
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemistry in the diagnosis of the gestational trophoblastic disease.
Lösch A; Kainz C
Acta Obstet Gynecol Scand; 1996 Sep; 75(8):753-6. PubMed ID: 8906012
[TBL] [Abstract][Full Text] [Related]
7. Immunocytochemical localization of placental lactogen and chorionic gonadotropin in the normal placenta and trophoblastic tumors, with emphasis on intermediate trophoblast and the placental site trophoblastic tumor.
Kurman RJ; Young RH; Norris HJ; Main CS; Lawrence WD; Scully RE
Int J Gynecol Pathol; 1984; 3(1):101-21. PubMed ID: 6329973
[TBL] [Abstract][Full Text] [Related]
8. What is the optimal duration of human chorionic gonadotrophin surveillance following evacuation of a molar pregnancy? A retrospective analysis on over 20,000 consecutive patients.
Coyle C; Short D; Jackson L; Sebire NJ; Kaur B; Harvey R; Savage PM; Seckl MJ
Gynecol Oncol; 2018 Feb; 148(2):254-257. PubMed ID: 29229282
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical staining properties of PCNA, Ki-67, p53, beta-hCG and HPL in trophoblastic disease.
Ozbilim G; Karaburun SP; Zorlu G; Kaya R; Erdoğan G; Karaveli S
Eur J Gynaecol Oncol; 2000; 21(2):200-4. PubMed ID: 10843487
[TBL] [Abstract][Full Text] [Related]
10. A clinico-pathological study of complete and partial hydatidiform moles in a Nigerian population.
Osamor JO; Oluwasola AO; Adewole IF
J Obstet Gynaecol; 2002 Jul; 22(4):423-5. PubMed ID: 12521470
[TBL] [Abstract][Full Text] [Related]
11. Cytological distribution of chorionic gonadotropin subunit and placental lactogen messenger RNA in neoplasms derived from human placenta.
Hoshina M; Hussa R; Pattillo R; Boime I
J Cell Biol; 1983 Oct; 97(4):1200-6. PubMed ID: 6619191
[TBL] [Abstract][Full Text] [Related]
12. [Expression of human chorionic gonadotropin, human placental lactogen and pregnancy-specific 1-glycoprotein in malignant trophoblastic neoplasms].
Xiong YY; Zeng J; Tang ZJ
Zhonghua Fu Chan Ke Za Zhi; 1994 Oct; 29(10):610-3, 638. PubMed ID: 7712876
[TBL] [Abstract][Full Text] [Related]
13. P57
Awosusi BL; Ajani MA; Adegoke OO; Salami AA; Okolo CA
Niger Postgrad Med J; 2020; 27(4):331-335. PubMed ID: 33154286
[TBL] [Abstract][Full Text] [Related]
14. [Clinical characteristics and diagnosis of early hydatidiform mole].
Jiao LZ; You SY; Wang YP; Zhu CG; Jiang JY
Zhonghua Fu Chan Ke Za Zhi; 2019 Nov; 54(11):756-762. PubMed ID: 31752459
[No Abstract] [Full Text] [Related]
15. Partial hydatidiform moles have impaired differentiated function (human chorionic gonadotropin and human placental lactogen secretion) in response to epidermal growth factor and 8-bromo-cyclic adenosine monophosphate.
Morrish DW; Honoré LH; Bhardwaj D
Am J Obstet Gynecol; 1992 Jan; 166(1 Pt 1):160-6. PubMed ID: 1370741
[TBL] [Abstract][Full Text] [Related]
16. A Case of Rapid Transformation from Hydatidiform Mole to Invasive Mole: The Importance of β-hCG (Human Chorionic Gonadotropin) Serum Levels in Follow-Up Evaluation.
Harsono AB; Hidayat YM; Winarno GNA; Nisa AS; Alkaff FF
Am J Case Rep; 2021 Jun; 22():e931156. PubMed ID: 34127641
[TBL] [Abstract][Full Text] [Related]
17. Challenges in the Routine Praxis Diagnosis of Hydatidiform Mole: a Tertiary Health Center Experience.
Lelic M; Fatusic Z; Iljazovic E; Ramic S; Markovic S; Alicelebic S
Med Arch; 2017 Aug; 71(4):256-260. PubMed ID: 28974845
[TBL] [Abstract][Full Text] [Related]
18. Serum human placental lactogen (HPL) levels in patients with intact hydatidiform mole.
Lim YC; Chew SC; Ratnam SS
Acta Obstet Gynecol Scand; 1976; 55(5):407-12. PubMed ID: 187001
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis and outcome of hydatidiform moles in missed-miscarriage: a cohort-study, systematic review and meta-analysis.
Memtsa M; Johns J; Jurkovic D; Ross JA; Sebire NJ; Jauniaux E
Eur J Obstet Gynecol Reprod Biol; 2020 Oct; 253():206-212. PubMed ID: 32877774
[TBL] [Abstract][Full Text] [Related]
20. Loss of p57 Expression in Conceptions Other Than Complete Hydatidiform Mole: A Case Series With Emphasis on the Etiology, Genetics, and Clinical Significance.
Xing D; Miller K; Beierl K; Ronnett BM
Am J Surg Pathol; 2022 Jan; 46(1):18-32. PubMed ID: 34074808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
